Skip to main content

GE HealthCare Technologies Inc

For the period ended Dec 31, 2024. Filed Feb 13, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 13, 2025

GEHC$83.65-0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated and Combined Statements of Cash Flows

Consolidated and Combined Statements of Cash Flows
For the years ended December 31
(In millions)202420232022
Net income$2,050$1,614$1,967
Less: Income (loss) from discontinued operations, net of taxes—(4)18
Net income from continuing operations$2,050$1,618$1,949
Adjustments to reconcile Net income from continuing operations to Cash from (used for) operating activities – continuing operations
Depreciation of property, plant, and equipment268248228
Amortization of intangible assets312362405
Gain on fair value remeasurement of contingent consideration(19)(17)(65)
Net periodic postretirement benefit plan (income) expense(357)(332)9
Postretirement plan contributions(332)(357)(18)
Share-based compensation12511467
Provision for income taxes531743563
Cash paid during the year for income taxes(491)(474)(851)
Changes in operating assets and liabilities, excluding the effects of acquisitions:
Receivables(178)(185)(231)
Due from related parties25413
Inventories(81)111(402)
Contract and other deferred assets310(222)
Accounts payable126(13)481
Due to related parties(61)(84)(33)
Contract liabilities6826138
Current compensation and benefits39153(37)
All other operating activities – net(74)174140
Cash from (used for) operating activities – continuing operations1,9552,1012,134
Cash flows – investing activities
Additions to property, plant and equipment and internal-use software(401)(387)(310)
Dispositions of property, plant, and equipment—14
Purchases of businesses, net of cash acquired(313)(147)—
Purchases of investments(40)(48)(59)
All other investing activities – net(160)23(33)
Cash from (used for) investing activities – continuing operations(914)(558)(398)
Cash flows – financing activities
Net increase (decrease) in borrowings (maturities of 90 days or less)—(12)9
Newly issued debt, net of debt issuance costs (maturities longer than 90 days)9952,0068,198
Repayments and other reductions (maturities longer than 90 days)(1,418)(855)(3)
Dividends paid to stockholders(55)(41)—
Redemption of noncontrolling interests—(211)—
Net transfers (to) from GE—(1,317)(8,934)
Proceeds from stock issued under employee benefit plans3334—
Taxes paid related to net share settlement of equity awards(93)(33)—
All other financing activities – net(34)(49)(92)
Cash from (used for) financing activities – continuing operations(573)(478)(822)
Cash from (used for) operating activities – discontinued operations(4)—(21)
Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash(77)(10)(3)
Increase (decrease) in cash, cash equivalents, and restricted cash3871,055890
Cash, cash equivalents, and restricted cash at beginning of year2,5061,451561
Cash, cash equivalents, and restricted cash at end of year$2,893$2,506$1,451
Supplemental disclosure of cash flows information
Cash paid during the year for interest$(550)$(570)$—
Non-cash investing activities
Acquired but unpaid property, plant, and equipment$143$140$136
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.